I’m writing this column in my hotel room in rainy, somewhat chilly, Copenhagen. So much for the summer dresses that I packed in preparation for attending this European League Against Rheumatism (EULAR) meeting. Instead it’s been all about layering and trying to stay dry, dodging puddles, and struggling with blown-out umbrellas. The rain has impeded any desire to explore Tivoli gardens, but it hasn’t dampened the friendliness and welcome of our European counterparts in EULAR’s Allied Health Professionals (AHP) standing committee.
Within Our Reach–Funded Research May Hold Key to Unlocking the CNS and Suppressing RA
Studies recently published in Arthritis & Rheumatism show that a key chemical produced by the central nervous system (CNS) decreases inflammation and suppresses production of proteins known to play a role in rheumatoid arthritis (RA). This opens the way for developing a novel class of drugs that mimic this effect of the CNS on RA.
Pharmaceutical Tourism
Could trade agreements and not bulky legislation be the key to cheaper drugs?
The Canes of York
What can a walking stick tell us about U.S. healthcare?
The Health Buzz
What is the ACR doing with healthcare reform?
A New Home for the ACR
The Atlanta headquarters are moving to a building purchased by the College
H1N1 Influenza A Virus Brings Many Questions, Few Answers
Rheumatologists grapple with vaccine concerns and the impact of medications on response
Neurological Piece of the Fibromyalgia Puzzle
Exploring the peripheral and central elements of pain in FM
Rheumatology Guy
Sung to the Tune of “American Pie”
Another Vocabulary for Rheumatology Research
Matt Liang, MD, MPH, addresses patients’ authentic concerns
- « Previous Page
- 1
- …
- 752
- 753
- 754
- 755
- 756
- …
- 815
- Next Page »